The stock of Precigen Inc. (NASDAQ:PGEN) increased by $0.25 on Friday to finish at $1.79, up 16.56 percent. The last five days have seen an average of 2,726,136 shares of common stock traded. 10 times new highs were reached in the current year, with a gain of $0.2400. The average number of shares traded over the last 20 days was 1,637,614, while the average volume over the last 50 days totaled 1,416,746.
PGEN stock appreciated 52.12% since last month. On 08/07/23, the company’s shares reached a one-month low of $1.0600. The stock touched a high of $2.90 on 01/23/23, after rallying from a low of $0.81 in 52 weeks. The price of PGEN stock has risen by 18.09% or $0.2400 this year, reaching a new high 10 times. Still, the stock price is down -38.10% from the 52-week high.
Insider Transactions
PGEN stock investors should be aware that Precigen Inc. (PGEN) stock had its last reported insider trading activity 3 days ago on Aug 11. On Aug 11, President and CEO Sabzevari Helen sold 41,436 shares at $1.44 each. This transaction resulted in the insider making $59,668. On Aug 10, Lehr Donald P. sold 11,026 shares at a price of US$1.21. After the transaction, the insider now owns 407,205 shares. SVP, IP Affairs Perez Jeffrey Thomas had earlier sold 8,956 shares on Aug 10 for $1.21 a share. The transaction was completed for $10,837.
Valuation Metrics
Beta for the stock is 1.90. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 19.51, the price-to-book (PB) ratio of 2.24.
Financial Health
For the three months ended June 29, Precigen Inc.’s current ratio was 2.90. As far as profitability goes, gross margin for the trailing twelve months is 73.50% percent. Based on annual data, it had gross profit of $20.57 million and revenue of $26.91 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. PGEN’s return on assets (ROA) during the last 12 months has been 10.90%. There was a -44.60% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 22.30%.
Earnings Surprise
According to Precigen Inc.’s quarterly financial report for the quarter that ended June 29, it had $71.89 million in cash and short-term investments. A lower net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $1.77 million, while revenues fell by -64.41% to $1.85 million. It was predicted that Precigen Inc.’s quarterly earnings would be -$0.08, but it ended up being -$0.1. EBITDA was -$19.92 million for the quarter. At the end of Precigen Inc.’s most recent quarter ended June 29, its liabilities totaled 41.32 million, while its total debt was $7.97 million. Equity owned by shareholders amounts to $255.48 million.
Technical Picture
Here’s a quick look at Precigen Inc.’s (PGEN) price momentum from a technical perspective. As of 11 August, the RSI 9-day stood at 80.63%, suggesting the stock is Overbought, with a 131.13% historical volatility rate.
The stochastic %K and %D were 88.14% and 70.79% respectively, while the average true range (ATR) was 0.1566. Based on the 14-day stochastic reading of 96.55%, the RSI (14) reading is 74.24%. On the 9-day MACD Oscillator, the stock is at 0.2967, and the 14-day reading is at 0.2945.
Analyst Ratings
In its analyst report released on May 23, 2023, JP Morgan began covering Precigen Inc. (NASDAQ: PGEN). The stock was rated as a Neutral by the brokerage firm. Analysts have assigned Precigen Inc. (PGEN) an Buy rating. PGEN is a stock that is recommended for selling by 0 brokerage firms, while 1 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 4 others recommend it as a buy.
What is PGEN’s price target for the next 12 months?
The current consensus forecast for the stock is between $6.00 and $14.00, with a median target price of $9.00. In analyzing these forecasts, the average price target given by analysts for Precigen Inc. (PGEN) is $9.50.
